PortfoliosLab logoPortfoliosLab logo
RLYB vs. CLNN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RLYB vs. CLNN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rallybio Corporation (RLYB) and Clene Inc. (CLNN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RLYB achieves a 192.78% return, which is significantly higher than CLNN's -1.87% return.


RLYB

1D
-0.99%
1M
13.81%
YTD
192.78%
6M
204.36%
1Y
583.02%
3Y*
-36.91%
5Y*
10Y*

CLNN

1D
-1.87%
1M
-28.80%
YTD
-1.87%
6M
-20.22%
1Y
46.94%
3Y*
-34.82%
5Y*
-51.34%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

RLYB vs. CLNN - Yearly Performance Comparison


2026 (YTD)20252024202320222021
RLYB
Rallybio Corporation
192.78%-28.53%-59.83%-63.62%-31.13%-32.34%
CLNN
Clene Inc.
-1.87%10.55%-10.49%-70.34%-75.61%-49.32%

Correlation

The correlation between RLYB and CLNN is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (All Time)
Calculated using the full available price history since Jul 30, 2021

0.12

Fundamentals

Market Cap

RLYB:

$91.42M

CLNN:

$67.07M

EPS

RLYB:

-$1.41

CLNN:

-$3.24

PS Ratio

RLYB:

103.99

CLNN:

443.94

Total Revenue (TTM)

RLYB:

$858.00K

CLNN:

$134.00K

Gross Profit (TTM)

RLYB:

$643.00K

CLNN:

$96.00K

EBITDA (TTM)

RLYB:

-$32.06M

CLNN:

-$23.91M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Rallybio Corporation

Clene Inc.

Often compared with RLYB:
RLYB vs. CNSP

Return for Risk

RLYB vs. CLNN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RLYB
RLYB Risk / Return Rank: 9898
Overall Rank
RLYB Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
RLYB Sortino Ratio Rank: 9898
Sortino Ratio Rank
RLYB Omega Ratio Rank: 9696
Omega Ratio Rank
RLYB Calmar Ratio Rank: 9999
Calmar Ratio Rank
RLYB Martin Ratio Rank: 9999
Martin Ratio Rank

CLNN
CLNN Risk / Return Rank: 5858
Overall Rank
CLNN Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
CLNN Sortino Ratio Rank: 6464
Sortino Ratio Rank
CLNN Omega Ratio Rank: 6363
Omega Ratio Rank
CLNN Calmar Ratio Rank: 5656
Calmar Ratio Rank
CLNN Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RLYB vs. CLNN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Rallybio Corporation (RLYB) and Clene Inc. (CLNN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RLYBCLNNDifference

Sharpe ratio

Return per unit of total volatility

5.04

0.43

+4.61

Sortino ratio

Return per unit of downside risk

5.33

1.43

+3.90

Omega ratio

Gain probability vs. loss probability

1.62

1.18

+0.44

Calmar ratio

Return relative to maximum drawdown

18.95

0.69

+18.26

Martin ratio

Return relative to average drawdown

44.22

1.18

+43.03

RLYB vs. CLNN - Sharpe Ratio Comparison

The current RLYB Sharpe Ratio is 5.04, which is higher than the CLNN Sharpe Ratio of 0.43. The chart below compares the historical Sharpe Ratios of RLYB and CLNN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


RLYBCLNNDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

5.04

0.43

+4.61

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.50

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.30

-0.42

+0.11

Drawdowns

RLYB vs. CLNN - Drawdown Comparison

The maximum RLYB drawdown since its inception was -98.93%, roughly equal to the maximum CLNN drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for RLYB and CLNN.


Loading charts...

Drawdown Indicators


RLYBCLNNDifference

Max Drawdown

Largest peak-to-trough decline

-98.93%

-99.27%

+0.34%

Max Drawdown (1Y)

Largest decline over 1 year

-31.05%

-68.64%

+37.59%

Max Drawdown (3Y)

Largest decline over 3 years

-97.19%

-89.13%

-8.06%

Max Drawdown (5Y)

Largest decline over 5 years

-99.13%

Current Drawdown

Current decline from peak

-91.42%

-98.23%

+6.81%

Average Drawdown

Average peak-to-trough decline

-79.17%

-84.68%

+5.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.28%

39.77%

-26.49%

Volatility

RLYB vs. CLNN - Volatility Comparison

The current volatility for Rallybio Corporation (RLYB) is 19.93%, while Clene Inc. (CLNN) has a volatility of 30.10%. This indicates that RLYB experiences smaller price fluctuations and is considered to be less risky than CLNN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RLYBCLNNDifference

Volatility (1M)

Calculated over the trailing 1-month period

19.93%

30.10%

-10.17%

Volatility (6M)

Calculated over the trailing 6-month period

72.03%

75.50%

-3.47%

Volatility (1Y)

Calculated over the trailing 1-year period

116.79%

111.80%

+4.99%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

109.57%

103.31%

+6.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

109.57%

112.76%

-3.19%

Dividends

RLYB vs. CLNN - Dividend Comparison

Neither RLYB nor CLNN has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

RLYB vs. CLNN - Financials Comparison

This section allows you to compare key financial metrics between Rallybio Corporation and Clene Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00K100.00K150.00K200.00K250.00K300.00K20222023202420252026
212.00K
15.00K
(RLYB) Total Revenue
(CLNN) Total Revenue
Values in USD except per share items

Frequently Asked Questions


RLYB and CLNN have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CLNN has higher volatility (30.10%) compared to RLYB (19.93%). In terms of maximum drawdown, RLYB dropped -98.93% vs CLNN's -99.27%.

RLYB currently has the higher Sharpe Ratio (5.04 vs 0.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RLYB and CLNN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer